• 2nd World Congress on Advances on Addiction Science and Medicine - Sobriety through Information on Addiction Science and Research July 24,25 Rome, Italy: Pulsus Group, Addiction Science 2019 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “2nd World Congress on Advances in Addiction Science and Medicine" which is going to be held during July 24,25 Rome, Italy. Addiction Science 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. The scientific program will focus on current advances in the research and leading strategies in plant and herbal medicine and its development with a theme “Sobriety through Information on Addiction Science and Research” and the conference highlights are: Addiction Drugs and Abuse, Classification of Addiction Drugs, Causes and Consequences, Reward of Addiction, Substance Use Disorders, Pharmacotherapy, Rehabilitation and Risk management, Most Commonly used Addiction Drugs, Addiction Psychiatry and Mental Health, Phases of Recovery, Social Support for Addiction, Treatment Community, Self Help for Cure, Recuperation in Recovery, Characteristics of Drug Addicts, Drug Abuse Physical Warning, Stages of Addiction, Screening Tools for Drug Addicts, Food addiction, Prescription drug addiction, Gambling addiction, Gaming addiction and more The conference will feature keynote presentations by top professionals as well as renowned experts in the field from all around the globe. In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for pharmacy educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Pharmacy and Pharmaceutical Sciences. Conference Highlights: • 100+ Participation (70 Industry: 30 Academia) • 5+ Keynote Speakers • 50+ Plenary Speakers • 20+ Exhibitors • 14 Innovative Educational Sessions • 5+ Workshops • B2B Meetings (Added: Fri Mar 15 2019 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• 2nd World Congress on Advances on Addiction Science and Medicine - Sobriety through Information on Addiction Science and Research July 24,25 Rome, Italy: Pulsus Group, Addiction Science 2019 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “2nd World Congress on Advances in Addiction Science and Medicine" which is going to be held during July 24,25 Rome, Italy. Addiction Science 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. The scientific program will focus on current advances in the research and leading strategies in plant and herbal medicine and its development with a theme “Sobriety through Information on Addiction Science and Research” and the conference highlights are: Addiction Drugs and Abuse, Classification of Addiction Drugs, Causes and Consequences, Reward of Addiction, Substance Use Disorders, Pharmacotherapy, Rehabilitation and Risk management, Most Commonly used Addiction Drugs, Addiction Psychiatry and Mental Health, Phases of Recovery, Social Support for Addiction, Treatment Community, Self Help for Cure, Recuperation in Recovery, Characteristics of Drug Addicts, Drug Abuse Physical Warning, Stages of Addiction, Screening Tools for Drug Addicts, Food addiction, Prescription drug addiction, Gambling addiction, Gaming addiction and more The conference will feature keynote presentations by top professionals as well as renowned experts in the field from all around the globe. In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for pharmacy educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Pharmacy and Pharmaceutical Sciences. Conference Highlights: • 100+ Participation (70 Industry: 30 Academia) • 5+ Keynote Speakers • 50+ Plenary Speakers • 20+ Exhibitors • 14 Innovative Educational Sessions • 5+ Workshops • B2B Meetings If you would like to know more information about this conference, to book a slot, Sponsorship and Exhibit sales information, please Contact: Nivetha M Tel.: 408-429-2646 Email: addictionscience@pulsusmeetings.net Website: https://addiction.cmesociety.com/  ^pop (Added: Fri Mar 15 2019 Hits: 121 Rating: 0.00 Votes: 0) Rate It

• 2nd World Congress on Advances on Addiction Science and Medicine - Sobriety through Information on Addiction Science and Research July 24,25 Rome, Italy: Pulsus Group, Addiction Science 2019 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “2nd World Congress on Advances in Addiction Science and Medicine" which is going to be held during July 24,25 Rome, Italy. Addiction Science 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. The scientific program will focus on current advances in the research and leading strategies in plant and herbal medicine and its development with a theme “Sobriety through Information on Addiction Science and Research” and the conference highlights are: Addiction Drugs and Abuse, Classification of Addiction Drugs, Causes and Consequences, Reward of Addiction, Substance Use Disorders, Pharmacotherapy, Rehabilitation and Risk management, Most Commonly used Addiction Drugs, Addiction Psychiatry and Mental Health, Phases of Recovery, Social Support for Addiction, Treatment Community, Self Help for Cure, Recuperation in Recovery, Characteristics of Drug Addicts, Drug Abuse Physical Warning, Stages of Addiction, Screening Tools for Drug Addicts, Food addiction, Prescription drug addiction, Gambling addiction, Gaming addiction and more The conference will feature keynote presentations by top professionals as well as renowned experts in the field from all around the globe. In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for pharmacy educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Pharmacy and Pharmaceutical Sciences. Conference Highlights: • 100+ Participation (70 Industry: 30 Academia) • 5+ Keynote Speakers • 50+ Plenary Speakers • 20+ Exhibitors • 14 Innovative Educational Sessions • 5+ Workshops • B2B Meetings If you would like to know more information about this conference, to book a slot, Sponsorship and Exhibit sales information, please Contact: Nivetha M Tel.: 408-429-2646 Email: addictionscience@pulsusmeetings.net Website: https://addiction.cmesociety.com/  ^pop (Added: Fri Mar 15 2019 Hits: 135 Rating: 0.00 Votes: 0) Rate It

• Global Restorative Dentistry market - Global Restorative Dentistry market is expected to reach USD 21.27 Billion by 2026 at a CAGR of 6.5 % during the forecast period. The Global Restorative Dentistry market is segmented based on based on product, end-user, and region. By Product type - Restorative Materials, Implants, Prosthetics, Restorative Equipment. By End-users - Hospitals & Clinics, Dental Laboratories, Dental Schools & Research Institutes. By region - North America, South America, Europe, Asia-Pacific, Middle East, and Africa Restorative dentistry is the study, diagnosis, and management of teeth disease and supporting structure of teeth. It includes endodontics, periodontics and prosthodontics and these are basically used in sealants/filling, inlays, onlays, crown/bridges, CAD/CAM, VENEERS. Major Market Drivers: • Increasing number of dental practices. • New digital density technology. • Rising demand for cosmetic dentistry and implant. • Increasing number of dental tourism. Restraint: • High cost of product hinders the growth of this market. • Less reimbursement of dental procedure restrains this market. Strategic Developments in the Global Restorative Dentistry Market: In 2018, Inverness Graham (U.S.) acquired Vista Dental (U.S.).By this acquisition, the company enhanced the business growth in the dental restorative market. In 2017, Dentsply Sirona (U.S.) acquired RTD (France) company. By this acquisition, a company acquired outstanding shares of RTD. According to an agreement, Dentsply Sirona continued to support and growth of the brand and private label business of RTD. Product Insights: Restorative materials and restorative equipment segment are expected to reveal exponential CAGR throughout the forecast period due to innovative product launches, and the increasing number of dental implantation procedures across the globe. The North American region is playing the principal role in the global restorative dentistry market due to an increasing number of cosmetic dental procedures in the U.S. and Canada. Though, Asia-Pacific will be the second major market in the proximate. The presence of innovative dental advanced technology and the rising incidence of losing teeth, tooth decay, and other dental complications in the region. For more information visit @https://www.maximizemarketresearch.com/market-report/global-restorative-dentistry-market/14877/ Scope of the Global Restorative Dentistry Market Report Global Restorative Dentistry Market, Product • Restorative Materials • Implants • Prosthetics • Restorative Equipment Global Restorative Dentistry Market, by End Users • Hospitals & Clinics • Dental Laboratories • Dental Schools & Research Global Restorative Dentistry Market, By Region • North America • Europe • Asia Pacific • Middle East • Africa Global Restorative Dentistry Market Key Players • COLTENE Group • Septodont Holding • Voco GmbH • Ultradent Products, Inc • Zimmer Biomet • Institut Straumann AG • Mitsui Chemicals, Inc. • Ivoclar Vivadent AG • 3M • Danaher • Dentsply Sirona • SDI Limited SHOFU DENTAL • BISCO, Inc. • Datenschutz • Henry Schein, Inc. • BOTISS • KaVo Kerr • Keystone Dental, Inc. • Jensen Dental • VITA • Zhermack SpA • Zubler. Reasons to Purchase this Report: • Current and future of global deep global restorative dentistry market, the outlook in the developed and emerging markets. • The segment that is predictable to lead the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period. • The latest innovative developments, market shares, and strategies that are employed by the major market players. This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908  ^pop (Added: Fri Mar 15 2019 Hits: 111 Rating: 0.00 Votes: 0) Rate It

• Global Interventional Radiology market - Global Interventional Radiology market is expected to reach USD 55.5% Billion by 2026 at a CAGR of 6.5 % during the forecast period. The Global Interventional Radiology market is segmented based on based on product, procedure, application, and region. Based on the product - MRI systems, ultrasound imaging systems, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, other devices. Among the procedures - angiography, angioplasty, biopsy devices, embolization, thrombolysis, vertebroplasty, nephrostomy, other procedures. Based on application - cardiology, urology & nephrology, oncology, gastroenterology, other applications. By region - North America, South America, Europe, Asia-Pacific, Middle East, and Africa Interventional radiology is also known as vascular radiology. It is providing minimally invasive image-guided diagnosis and treatment of disease. It includes fluoroscopy, ultrasound, computed tomography [CT] or magnetic resonance imaging [MRI]). Interventional radiology has the number of advantage include risk, pain and recovery time often reduces, it is less expensive than surgery or other alternatives. Major Market Drivers: • Increasing interventional radiology application. • Rising prevalence of cancer. • Increasing demand for minimally invasive procedures. • Technology advancement in interventional radiology devices. Restraint: • Risk of high radiation exposure to limit the use of CT scanners. • Shortage of helium which is the major challenge for MRI manufacturer and healthcare facilities. • Less reimbursement scenario hinders the growth. Global Interventional Radiology market Strategic Developments in the Global Interventional Radiology Market: In 2018, Guerbet was completely acquired accurate medical therapeutics. By this acquisition, the company enhances their presence. In 2015, Boston Scientific acquired CeloNova Biosciences. By this acquisition, company enhanced product portfolio in interventional radiology business. Product Insights: MRI system and ultrasound imaging system segment are expected to reveal exponential CAGR throughout the forecast period due to, increasing interventional radiology application and rising prevalence of cancer across the globe. The North American region is playing the principal role in the global interventional radiology market due to increasing demand for minimally invasive procedures and technology advancement in interventional radiology devices in the U.S. and Canada. Though, Asia-Pacific will be the second major market in the proximate. The presence of innovative advanced technology, increasing interventional radiology application and the rising prevalence of cancer in the region For more information visit @https://www.maximizemarketresearch.com/market-report/global-interventional-radiology-market/14936/ Scope of the Global Interventional Radiology Market: Global Interventional Radiology Market, By Product • MRI systems • Ultrasound imaging systems • CT scanners, angiography systems • Fluoroscopy Systems • Biopsy devices • Others Global Interventional Radiology Market, By Procedure • Angiography • Angioplasty • Biopsy devices • Embolization • Thrombolysis • Vertebroplasty • Nephrostomy • Others Global Interventional Radiology Market, By Application • Cardiology • Urology & Nephrology • Oncology • Gastroenterology • Others Global Interventional Radiology Market, By Region: • North America • Europe • Asia Pacific • Middle East & Africa • South America Key Players Operating In Global Interventional Radiology Market: • Koninklijke Philips N.V. • GENERAL ELECTRIC • CANON MEDICAL SYSTEMS CORPORATION • Siemens Healthcare Private Limited • Hitachi Medical Corporation • Teleflex Incorporated • Medtronic • FUJIFILM Holdings Corporation • Agfa-Gevaert Group. • Carestream Health • Esaote SpA. • Samsung Medison Co., Ltd • Shimadzu Corporation • Biosensors International Group, Ltd. • Stryker • Cook Group • Emergence Teleradiology LLC • Agilent Technologies, Inc • Carestream Health • Barco Electronic Systems Pvt. Ltd. • Elekta AB • Nordion (Canada) Inc. • PLANMED OY • Hologic Inc. • SectraAB,Atlantis Wordwide • NCD Corporation,Sharedimaging • All Star X-ray • Amber • Jones X-Ray • OzarkImaging • EXCEL IMAGING, INC. • AMD Technologies, Inc. • ScImageInc • SonoSite, Inc. • Reasons to Purchase this Report: • Current and future of global deep global interventional radiology market, the outlook in the developed and emerging markets. • The segment that is predictable to lead the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period. • The latest innovative developments, market shares, and strategies that are employed by the major market players. This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908  ^pop (Added: Fri Mar 15 2019 Hits: 141 Rating: 0.00 Votes: 0) Rate It

• Radiation-Induced Myelosuppression Treatment Market -

  

  Rapidly improving healthcare infrastructure and reimbursement scenario has been a major booster for the healthcare industry in developing regional markets. With incessantly increasing number of cancer cases, it is more likely that the subsequent demand for a wide range of treatments adopted to treat cancer patients would also remain on a constant rise over the course of coming years.

  Radiation therapy has been a significant part of cancer treatment and the consistently high success rate associated with radiotherapy is projected to further push demand for radiation-induced myelosuppression treatment worldwide.

  A new market research study on global radiation-induced myelosuppression treatment forecasts steady growth for the market in the next few years. Future Market Insights projects a moderate, just-under 4% yearly growth outlook, in 2019 and ahead.

  Nutropenia is foreseen to generate maximum demand for radiation-induced myelosuppression treatment, whereas injectables are identified to hold a substantial share in the total market value, based on the route of administration of radiation-induced myelosuppression treatment. Thrombocytopenia and anemia are likely to present lucrative opporunities for radiation-induced myelosuppression treatment providers.

  Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8116 

  Report tracks key factors driving revenue growth of the market -

  • Increasing prevalence of cancers

  • Early diagnosis, promising improved chances of positive outcomes

  • Fostering R&D funds supporting cancer research

  • Strong product pipeline

  • Bolstering adoption of chemo-radiotherapy in cancer treatment

  In the backdrop of patent expiry, a majority of market leaders are shifting their focus to the expansion of product pipeline of a wide range of innovative formulations, likely to shape the radiation-induced myelosuppression treatment landscape.

  • Myelo001 by Myelo Therapeutics GmbH recently received an FDA approval as an orphan drug to be used in the ARS (acute radiation syndrome) treatment.

  • Mylan NV and Pfizer Inc. also reveived FDA approvals for their recently launched biosimilars - Epogen and Neupogen, and Neulasta respectively.

  Patent expiry of originator biologics formulations is creating investment opportunities in biosimilars production – for the operators in radiation-induced myelosuppression treatment landscape. As there is a considerable cost difference of around 20% between originator biologics and biosimilars, patients are inclined more towards an economical means of treatment, thereby fueling the scope of penetration of radiation-induced myelosuppression treatment in coming years.

  Backed by a majority of established players housing strong bases across North America, especially the US, the report indicates a steady growth outlook for the radiation-induced myelosuppression treatment market in the region. North America will reportedly continue to account for over 65% share in the global market value.

  New product launches currently mark the top developmental strategy adopted by leading companies competing in the radiation-induced myelosuppression treatment market. A majority of key players are also identified to focus on enhancing their geographical foothold in global radiation-induced myelosuppression treatment landscape.  The report in a distinct section covers some of the key competitors operating in radiation-induced myelosuppression treatment marketplace, emphasizing their financial as well as strategic profiles in depth.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-8116

  A few of the profiled companies include Pfizer Inc., Janssen Pharmaceutical NV, Janssen Global Services, LLC (Johnson & Johnson), Amgen Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., Novartis AG, and Partner Therapeutics, Inc.

  In the highly consolidated competitive landscape of global radiation-induced myelosuppression treatment, the three top ranking companies, i.e. Janssen Pharmaceutical NV, Amgen Inc., and Teva Pharmaceutical Industries Ltd. dominate in terms of market value. These players continue to hold winning revenue shares in the radiation-induced myelosuppression treatment owing to strong global presence and a considerable number of new drug approvals. Established companies are entering strategic partnerships and collaborations with regional leaders, in an effort to achieve better penetration into regional markets.

   ^pop (Added: Fri Mar 15 2019 Hits: 134 Rating: 0.00 Votes: 0) Rate It

• Global Dental Lab market - Global Dental Lab market is expected to reach USD 45.5% Billion by 2026 at a CAGR of 6.5 % during the forecast period. The Global Dental Lab market is segmented based on based on material, equipment, type, and g region Based on the material - Indirect Restorative Materials, Ceramics, and Other Indirect Restorative Materials. Among the equipment - Dental Milling Equipment, Dental Scanners, Furnaces, Dental Articulators. Based on types - Dental Bridges, Dental Crowns, Porcelain-Fused-To-Metal, Traditional All-Ceramics, Resins, Full-Cast Material, CAD/CAM Ceramics, and Dentures. By region - North America, South America, Europe, Asia-Pacific, Middle East, and Africa Dental laboratory manufactures a variety of product for the treatment of dental diseases. Dental laboratory product includes crown, bridges, texture. Dental laboratory products have come under medical device category which is regulated by FDA Major Market Drivers: • Rising geriatric population. • An increasing prevalence of edentulous. • Growing dental tourism. • Rising incidence of dental diseases. • Increasing outsourcing of customization and fabrication of restorative and prosthetic product in dental laboratories. Restraint: • High cost of dental material. Strategic Developments in the Global Dental Lab Market: In 2018, Garreco expanded dental laboratory business with the acquisition of Pemaco. This acquisition was provided dealers and lab technician’s access to the entire garreco line product including acrylics, abrasives, and rotary. In 2014, Henry Schein, Inc announced the acquisition of Lincoln Dental Supply. By this acquisition, company was expanding distribution business. Material Insights: Indirect restorative materials and ceramics segment are expected to reveal exponential CAGR throughout the forecast period due to, growing dental tourism and rising incidence of dental diseases. Across the globe. The North American region is playing the principal role in the global dental lab market due to an increasing prevalence of edentulous and growing dental tourism in the U.S. and Canada. Though, Asia-Pacific will be the second major market in the proximate. The presence of innovative advanced technology, increasing outsourcing of customization, fabrication of restorative and prosthetic product in dental laboratories in the region For more information visit @https://www.maximizemarketresearch.com/market-report/global-dental-lab-market/14945/ Scope of the Global Dental Lab Market Report Global Dental Lab Market, Material • Indirect Restorative Materials • Ceramics • Other Indirect Restorative Materials Global Dental Lab Market, by Equipment • Dental Milling Equipment • Dental Scanners • Furnaces • Dental Articulators Global Dental Lab Market, By Type • Dental Bridges • Dental Crowns • Porcelain-Fused-To-Metal • Traditional All-Ceramics • Resins • Full-Cast Material • CAD/CAM Ceramics • Dentures. Global Dental Lab Market, By Region • North America • Europe • Asia pacific • Middle East • Africa Global Dental Lab Market Key Players • Danaher • Zimmer Biomet • 3M • Ultradent Products, Inc. • Mitsui Chemicals, Inc. • GC Corporation • Planmeca • Septodont Holding • BEGO GmbH & Co. KG • Ivoclar Vivadent AG • VITA Zahnfabrik • SHOFU DENTAL • VOCO GmbH • Kuraray Noritake Dental, Inc. • Dentsply Sirona. • Knight Dental Design • 1st Dental Laboratories plc • Attenborough iDent Dental Lab • Champlain Dental Lab Inc. • National Dentex Labs. • A-dec Inc. • Dental Services Group • DentCare Dental Lab Pvt. Ltd • Blackfish Industries Co., Ltd • Shenzhen Jiayuanmei Dental Lab Co., Ltd • J & H Dental Lab • Dentsma Science and Technology Co., Ltd • Shengda Dental Lab • China Master Dental Office Co., Ltd • Qili Dental Department Technology Co.Ltd • Suzhou Same Dental Medical Co., Ltd • Reasons to Purchase this Report: • Current and future of global deep global dental lab market, the outlook in the developed and emerging markets. • The segment that is predictable to lead the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period. • The latest innovative developments, market shares, and strategies that are employed by the major market players. This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908  ^pop (Added: Fri Mar 15 2019 Hits: 121 Rating: 0.00 Votes: 0) Rate It

• Global Medical Case Management Services Market - The global medical case management services market features the dominance of a handful of big players that hold leading market shares. Large players are focused on expanding their presence in regional markets through partnerships and strategic collaborations with regional players. A case in point is GENEX Services Inc. In 2014, the company acquired M Hayes – a leading case medical case management firm that specializes in workers’ compensation and disability insurance. Key players in the global medical case management services market include EK Health Services Inc., EagleOne Case Management Solutions Inc., Healthcare Solutions Inc., Precyse Solutions LLC, and Europ Assistance – Global Corporate Solutions. The global medical case management services market is predicted to clock a CAGR of 3.04% for the forecast period between 2017 and 2021. Expanding at this pace, the market’s valuation of US$4573.4 in 2017 will become US$5,155.1 mn by the end of 2021. Request Sample Report@ https://www.persistencemarketresearch.com/samples/5294 Hospitals End-use Segment to Contribute Leading Revenue The global medical case management service market is studied in terms of mode of service, severity of case, end user, and region. Depending upon mode of service, web-based, field case, bilingual field, telephonic, and other services are the segments into which the medical case management services market is divided. Of them, telephonic case management service market is expected to continue to hold leading market share over the forecast period. Web-based medical case management service currently holds the second-leading share in this market; the segment anticipated to lose 40 BPS over the forecast period between 2017 and 2021. By end user, the medical case management service market is bifurcated into hospitals and home care settings. Of the two, hospitals is anticipated to account for the leading revenue contribution to the medical case management service market in the near future. This is mainly because of increasing rate of hospitalization coupled with increasing healthcare expenditure to opt for best treatment option. The increasing prevalence of chronic and long-term diseases also account for leading market share of hospital end-use segment. On the other hand, home care settings segment is predicted to exhibit a sluggish growth rate as very few people opt for home treatments for serious health conditions and severe injury. Depending upon severity of case, the medical case management service market is segregated into chronic pain case management, catastrophic case management, independent medical examinations, short-term disability, and long-term disability. Among them, long-term disability accounts for the leading revenue contribution to the overall market. Chronic pain case management segment is predicted to remain attractive through the forecast period. Request Report TOC@ https://www.persistencemarketresearch.com/methodology/5294 North America to Continue to Remain at the Forefront On the basis of geography, the medical case management service market is divided into Latin America, North America, Europe, the Middle East and Africa, and Asia Pacific. North America, among them, holds supremacy in the overall market; going forward, the region is anticipated to hold on to its dominant position. Europe ranks as the second-leading region due to substantial adoption of health insurance policy in the region. Asia Pacific medical case management services market is anticipated to emerge attractive due to rising medical tourism in emerging economies of the region. To summarize, the global medical case management services market is driven by rising healthcare expenditures and increasing prevalence of chronic diseases. Medical case management services aids to avoid unnecessary hospital admissions and helps to deliver informed patient care.  ^pop (Added: Fri Mar 15 2019 Hits: 129 Rating: 0.00 Votes: 0) Rate It

• Desiccators Market Growth and Sales Forecast 2018-2026 - Desiccators are laboratory equipment which assures dry, dust-free storage and organization of humidity sensitive products such as valuable reagents and biological samples. Desiccator cabinets can store biological samples at temperatures up to 120°F for use in incubators, freezers, refrigerators, or at room temperature. Desiccators absorb moisture from air in desiccator units. Desiccants are hygroscopic substances used as drying agents. Desiccator cabinets or canisters are sealed to absorb moisture. Once a moisture-sensitive object is placed inside the desiccator with the desiccant (or drying agent), it remains dry. These canisters or cabinets are sometimes referred to as desiccant dryers or desiccant dehumidifiers. Desiccator cabinets are made of glass & stainless steel or acrylic. Canisters are made of polypropylene, polycarbonate, and borosilicate. Acrylic desiccator cabinets can also be used in refrigerators for dry storage of moisture-sensitive materials. New generation desiccators are durable, have co-polyester construction blocks and a door seal which provides superior protection from moisture, convenient carrying handles, and digital hygrometer, besides automated continuous desiccant regeneration. Report Overview: https://www.transparencymarketresearch.com/desiccators-market.html A significant increase in use of desiccators in laboratories, extensive use of desiccators in various industries, increased funding by laboratories to support research and development activities, rise in collaboration between manufacturers and research institutes, technological advancement, and availability of advanced and new generation desiccators with better range of speed and settings are a few factors that are expected to propel the global desiccators market during the forecast period. However, high cost of desiccants and stringent regulatory approval are anticipated to hamper the global desiccators market. The global desiccators market can be segmented based on products, technology, end- user, and region. On the basis of product, the global desiccator market can be segmented into desiccator and desiccants & accessories. Desiccator can be further bifurcated into canister and cabinets. In terms of technology, the global desiccators market can be subdivided into standard, automatic, gas purge, and vacuum. Automatic desiccators use automatic desiccant regeneration method. Electric fans and heaters continuously regenerate the desiccant to prevent saturation and to automatically maintain a low humidity environment. Moreover, automatic desiccators have advantages such as precise control of humidity, operates on a set schedule of desiccation followed by a regeneration period. Thus, automatic desiccators are expected to propel the global desiccators market during the forecast period. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60462 Based on end-user, the global desiccators market can be segmented into academic institutes, research institutes, biotechnology & pharmaceutical companies. The biotechnology and pharmaceutical companies segment is expected to expand significantly in the next few years as the desiccation process is a part of the manufacturing process of various biotechnology- and pharmaceutical-based products available in the market. Based on region, the global desiccators market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a leading region of the desiccators market, driven by financial, economic, and technological development. Europe is a prominent region for the desiccator market. Most countries in Asia Pacific are emerging economies, with evolving R&D. This is expected to contribute to the growth of the desiccators market in the region. Latin America and Middle East & Africa offer a limited contribution to the global desiccators market due to underdeveloped research and development infrastructure of countries in this region. Request for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=60462 Key players operating in the global desiccators market includes DWK Life Sciences, Boekel Scientific, SP Scienceware - Bel-Art Products - H-B Instrument, Plas-Labs, Inc., Dynalon Labware, Corning Incorporated, Cole-Parmer Instrument Company, LLC, and Thermo Fisher Scientific Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Fri Mar 15 2019 Hits: 104 Rating: 0.00 Votes: 0) Rate It

• Handicap Assistive Robots Market Outlook to 2026 Scrutinized in New Research - Handicap assistive robots, also known as disability robots, are designed to help people who have physical disabilities that impede their daily tasks. These are also employed for people recovering from diseases such as stroke or abstained injuries. Children with severe physical disabilities become dependent on others and lose interests in their surroundings and studies. Robotic arms are becoming increasingly popular among them as they help them with their daily activities. The United Nations defines disability as a discrepancy that arises between personal abilities on one hand and demands of the environment and society on the other. Handicap assistive robots can sense, process sensory information, and perform actions that assist elderly people and people with disabilities. Rise in number of people suffering from physical disabilities is boosting the demand for assistive technologies. Assistive robots can be considered the future of disability aids, ensuring proper care of the elderly and disabled population. The global handicap assistive robots market is expected to grow rapidly during the forecast period owing to rise in adoption of advanced technologies such as robotics. Report Overview: https://www.transparencymarketresearch.com/handicap-assistive-robots-market.html Rise in adoption of microprocessor controlled prosthetics (MPC prosthetics), handicap assistive robots, and health care exoskeleton systems; increase in the number of accidents leading to disabilities; growing health care spending; and economic growth of countries with large number of people with disabilities such as India and China are likely to drive the global handicap assistive robots market during the forecast period. However, lack of awareness about available technologies and high cost of robotic devices are anticipated to restrain the growth of the market in developing regions of the world. The global handicap assistive robots market can be segmented based on product type, body function, robot’s mobility, end-user, and region. Based on product type, the market can be categorized into robotic wheelchairs, assistive robotic devices, and mobility-aid exoskeletons. Among these, robotic wheelchairs are likely to hold major share of the global handicap assistive robots market during the analysis period. In terms of body function, the global handicap assistive robots market can be classified into upper-extremity robots and lower-extremity robots. Based on robots mobility, the global handicap assistive robots market can be divided into mobile robots and fixed robots. In terms of end-user, the market can be bifurcated into hospitals, disability care centers, old age homes, home care settings, others. Based on region, the global handicap assistive robots market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to be the leading market for handicap assistive robots owing to the presence of large population suffering from physical disabilities, high disposable income, growing research and development activities, and launch of advanced robotic systems in the region. Moreover, government initiatives regarding care of handicap people and availability of favorable reimbursement policies are likely to propel the growth of the global handicap assistive robots market in North America during the forecast period. Europe is likely to be the second largest market for handicap assistive robots due to strong government funding and high awareness about advanced technologies for handicap persons in the region. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60459 Key players operating in the global handicap assistive robots market include Assistive Innovations BV, Bioness Inc., Ekso Bionics, Focal Meditech BV, Qode Interactive, Invacare Corporation, Kinova Inc., ReWalk Robotics, and Topchair SAS. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Fri Mar 15 2019 Hits: 111 Rating: 0.00 Votes: 0) Rate It

• Hemodialysis Chairs Market Opportunities in Key Application Sectors by 2026 - Blood and blood-related infections and chronic kidney disease (CKD) are considered major community health issues worldwide. According to a report by Britain’s National Kidney Federation published in 2014, more than 25,000 patients receive dialysis treatment every year and the number is anticipated to reach approximately 42,020 by the end of 2018. Hemodialysis, also known as kidney dialysis or merely dialysis, is a method of purifying the patient’s blood by using a dialysis machine. The number of patients affected by CKD is on the rise across the world. Therefore, the demand for hemodialysis chairs is increasing. The demand for these chairs has risen rapidly over the last few years. Report Overview: https://www.transparencymarketresearch.com/hemodialysis-chairs-market.html Hypertension and diabetes are key causes of chronic kidney disease (CKD). According to researchers, roughly 30%–40% of patients with chronic diabetes have risk of developing CKD in their lifetime. In comparison, high-blood pressure patients account for approximately 20% of all cases. For example, according to 2015 research findings by the National Health Survey, almost 15% of urban Indians are affected by chronic kidney disease (CKD). The global hemodialysis chairs market is estimated to expand rapidly in the next few years. A major driver of the market is increase in elderly population. The rate of incidence of severe renal disease, also known as final-stage CKD, is high among people aged between 48 and 60 years. These CKD patients require precise and longer treatments. CKD treatment ranges from dieting to regular dialysis and drug therapy. Public and private health care service companies have started implementing national awareness programs, due to low awareness about CKD diagnosis. This is likely to propel the global hemodialysis chairs market during the forecast period. Incidence as well as prevalence of CKD and blood-related diseases varies from region to region and country to country. Moreover, increase in unmet demand is anticipated to boost the global hemodialysis chairs market during the forecast period. For example, according to current research findings, the number of persons suffering from diabetes in India is estimated to get more than double by 2040. Advancements in technology and increase in per capita income are some of the factors that are estimated to drive the hemodialysis chairs market in developing countries, such as India, in the near future. However, factors such as limited reimbursement policies, high cost of treatment, and adverse effects caused by lack of hygiene and re-use of hemodialysis supplies are restraining the global hemodialysis chairs market. The global hemodialysis chairs market can be segmented based on product, end-user, and region. Based on product, the market can be classified into electric hemodialysis chairs and manual hemodialysis chairs. Based on position and technique, the electric hemodialysis chairs segment can be sub-divided into multi-positional chairs, fold-away arm supports, sliding footboards, and others. In terms of end-user, the global hemodialysis chairs market can be categorized into hospitals, ambulatory surgical centers, and home care settings. The hospitals segment is estimated to dominate the market in the next few years, followed by the home care settings segment. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60456 Based on region, the global hemodialysis chairs market can be classified into Europe, Asia Pacific, Middle East & Africa, North America, and Latin America. North America leads the global market. The market in Asia Pacific, which includes countries such as India, China, and the Philippines, is projected to be a lucrative market for hemodialysis chairs in the next few years. This is attributable to increase in attention of key players toward the region, rise in the number of dialysis centers operating independently, increase in the pool of CKD patients, increase in government health care expenditure, and growth in the number of programs to make available new and technologically advanced products for dialysis facilities. Some of the major players operating in the global hemodialysis chairs market are Baxter International, Inc., Digiterm (Hungary), Euroclinic, DaVita Healthcare Partners Inc., Medi-Plinth, and Acime-Frame. The global infection control market has been segmented based on equipment type, infection control services, infection prevention supplies, end-user, and region. In terms of equipment type, the global market can be classified into sterilization equipment, washing/disinfecting equipment, and others. Based on infection control services, the global infection control market can be bifurcated into infectious waste disposal services and contract sterilization. In terms of infection prevention supplies, the global market can be divided into infectious waste disposal, disinfectants, sterilization supplies, safety enhanced medical devices, and protective apparel & textiles. Based on end-user, the global infection control market can be categorized into hospitals & clinics, medical device companies, pharmaceutical companies, life sciences industry, food industry, and others. In terms of region, the global infection control market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major market share in 2017 owing to advanced health care infrastructure and rise in demand for infection control services in the region. Additionally, technological advancements in equipment utilized in sterilization procedures drive the market in the region. The U.S. accounted for major share of the infection control market in North America in terms of revenue in 2017, followed by Canada. Germany, France, and the U.K. held majority share of the infection control market in Europe in 2017. However, the infection control market in Asia Pacific is expected to expand at a high CAGR during the forecast period. This is due to increase in incidence of HAIs and rise in awareness about various types of infections in the region. Moreover, high disposable income, rise in demographics and economies in developing countries such as India and China are anticipated to fuel the growth in the infection control market in Asia Pacific. Request for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=60456 Major players in the global infection control market include Sakura Global Holding Company Ltd., Synergy Health plc, TSO3, Inc., 3M Company, STERIS Corporation, Nordion, Inc., Sterigenics International, Inc., Honeywell International, Inc., Matachana Group, Getinge Group, Cisa S.p.A, Belimed AG, Kimberly-Clark Corporation, Ahlstrom Corporation, and Johnson & Johnson Limited. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Fri Mar 15 2019 Hits: 113 Rating: 0.00 Votes: 0) Rate It

• Infection Control Market to Observe Significant Growth during 2018-2026 - The major causative microorganisms of infections are bacteria, virus, and fungi. However, infections can be classified into various types. These include lung and respiratory infections, hospital acquired infections (HAIs), ear infections, stomach & intestinal infections, eye infections, skin infections, common childhood infections, and sexually transmitted infections. These infections can be averted or controlled through a number of strategies. For instance, washing hands thoroughly is the most effective method of prevention of the spread of HAI. Other methods include following standard immunizations, covering your mouth while coughing and sneezing, using protective clothing such as gloves or masks, and always keeping tissues as well as hand cleaners handy. Report Overview: https://www.transparencymarketresearch.com/global-infection-control-market.html Factors such as increase in focus on food sterilization and disinfection; technological advancements pertaining to sterilization equipment, and rise in outsourcing of sterilization services among various pharmaceutical companies, hospitals, and medical equipment manufacturers are anticipated to propel the global infection control market. However, imposition of strict regulations for equipment approval in sterilization hampers the growth of the global market. The global infection control market has been segmented based on equipment type, infection control services, infection prevention supplies, end-user, and region. In terms of equipment type, the global market can be classified into sterilization equipment, washing/disinfecting equipment, and others. Based on infection control services, the global infection control market can be bifurcated into infectious waste disposal services and contract sterilization. In terms of infection prevention supplies, the global market can be divided into infectious waste disposal, disinfectants, sterilization supplies, safety enhanced medical devices, and protective apparel & textiles. Based on end-user, the global infection control market can be categorized into hospitals & clinics, medical device companies, pharmaceutical companies, life sciences industry, food industry, and others. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60453 In terms of region, the global infection control market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major market share in 2017 owing to advanced health care infrastructure and rise in demand for infection control services in the region. Additionally, technological advancements in equipment utilized in sterilization procedures drive the market in the region. The U.S. accounted for major share of the infection control market in North America in terms of revenue in 2017, followed by Canada. Germany, France, and the U.K. held majority share of the infection control market in Europe in 2017. However, the infection control market in Asia Pacific is expected to expand at a high CAGR during the forecast period. This is due to increase in incidence of HAIs and rise in awareness about various types of infections in the region. Moreover, high disposable income, rise in demographics and economies in developing countries such as India and China are anticipated to fuel the growth in the infection control market in Asia Pacific. Major players in the global infection control market include Sakura Global Holding Company Ltd., Synergy Health plc, TSO3, Inc., 3M Company, STERIS Corporation, Nordion, Inc., Sterigenics International, Inc., Honeywell International, Inc., Matachana Group, Getinge Group, Cisa S.p.A, Belimed AG, Kimberly-Clark Corporation, Ahlstrom Corporation, and Johnson & Johnson Limited. Request for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=60453 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Mar 15 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Spinal Intervention Market to Deliver Positive Growth Results until 2026 - Spinal intervention involves the treatment of all maladies that afflict the spine. The aim of spinal intervention is pain management, wherein the focus is solely on the spine. The spine consists of 33 bones, which include 12 thoracic vertebrae, seven cervical vertebrae, five sacral vertebrae, five lumbar vertebrae, and four coccygeal vertebrae. The pedicle, which is a stub of a bone that connects the lamina to the vertebral body to form an arch, is crucial in spinal intervention, as it offers a safe and secured tunnel. Through this tunnel, the interventionist examining the spine can get safe access to the vertebral body for vertebroplasty, biopsy, and kyphoplasty. The pedicles located in the cervical area are small and they have poor access to the vertebral body. The size of the pedicles gradually increases from the upper thoracic spine i.e. T4 to the lower lumbar spine i.e. L5. Progressive angulation occurs toward the cervical area from T4. Therefore, both pedicle size and angulation are equally important while planning a transpedicular procedure during intervention. Report Overview: https://www.transparencymarketresearch.com/spinal-intervention-market.html Spinal decompression is performed to create sufficient space for the nerves in the spinal canal, thereby diminishing the pain caused by neural impingement. Spinal fusion is performed to stop movement at one or more vertebral segments so as to relieve the pain and correct the spinal instability. The aim of spinal fusion is to unwind the spinal nerves that cause pain. This helps restore an appropriate gap between the vertebrae that surround the diseased disc, eliminating the pain caused during movement of the affected part. Increase in the incidence of complications associated with the spine is one of the factors expected to increase health care costs worldwide. Other major factors are rise in the incidence of neurological diseases and neck deformities caused by obesity and injuries and increase in the incidence of degenerative disc disease, spondylolisthesis, prolapsed intervertebral circle, herniated disc, and spinal stenosis. The global spinal intervention market is expected to expand significantly in the next few years, due to high investments by major players in R&D activities and availability of government funds for promoting advanced technologies. However, lack of skilled, highly qualified, and well-experienced medical practitioners; high costs of surgery; and lack of awareness among patients about diagnosis are expected to be restraining factors for the global spinal intervention market during the forecast period. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60450 The global spinal intervention market can be segmented based on surgery type, procedure type, technology, end-user, and region. Based on surgery type, the market can be segmented into open surgery and minimally invasive (MI) surgery. Due to occurrences of unsuccessful spinal surgeries, speedy research in newly developed techniques has been started to improve the outcome. Advancements in percutaneous techniques used in interventional procedures have lowered the invasive nature of the surgery. They have also avoided issues involved in open surgery such as infection and scarring. Based on procedure type, the global spinal intervention market can be classified into laminectomy, corpectomy, facetectomy, discectomy, and foraminectomy. Facetectomy is a procedure performed to remove the facet cartilage with the spine, which can promote easy fusion of bones. Non-fulfilment of this procedure can leave the facet articular cartilage inside, which may block the bone fusion by permitting the movement and contact between two cartilaginous surfaces in the particular part. Discectomy is a procedure allowing the removal of the herniated disc from the spinal canal. Laminectomy is a back surgery procedure performed to release the compressed spinal cord. Corpectomy is a procedure that helps relieve the damage caused to the vertebrae and the intervertebral discs. Foraminectomy is a spinal surgery procedure that decompresses the spinal nerves strained by the tissues, the disc material, or the bone that has narrowed the foraminal canal. Based on technology type, the global spinal intervention market can be classified into spinal fusion technology, spinal fixation technology, spinal non-fusion technology, annulus repair, dynamic stabilization, artificial disc replacement (or disc nucleus replacement), and vertebral compression fracture treatment. Based on end-user, the global spinal intervention market can be segregated into hospitals, research centers, and others. Geographically, the global spinal intervention market can be divided into five major regions: North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. The market in North America is expected to lead the global market during the forecast period, due to increasing number of spinal surgeries in countries in the region. Request for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=60450 Prominent players operating in the global spinal intervention market are Abbott Laboratories Ltd., Medtronic Inc, Zimmer Biomet Holdings Inc, Orthofix International N.V., Stryker Corporation, Globus Medical Inc, Boston Scientific Corporation, BioControl Medical Ltd., Synapse Biomedical Inc., and DePuy Synthes Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Mar 15 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• UK Sleeping Pill Gave an Update about the Due Inclusion of zopiclone Tablets in Their Inventory - It is true that presently, the world is filled with a large number of people who are suffering from anxiety and insomnia with ‘n’ number of reasons. However, the reasons behind such sickness is that because of unhealthy eating habits as well as poor standards of living, people all over the world are suffering from sickness like anything. Therefore, a popular benzodiazepine medication i.e. Zopiclone is considered the best aid for the short-term insomnia treatment including the anxiety disorders. Zopiclone is a broadly used sleeping tablet which is consumed to introduce a person with a perfectly sound sleep abreast with no disturbances. Thus, the best aid for the sufferers of anxiety and sleeplessness is here with consumption of Zopiclone. Zopiclone , as well as other benzodiazepines, act with an enhancement of the gamma-aminobutyric acid (GABA) directly inside the brain. Fundamentally, GABA is a neurotransmitter that easily inhibits almost all the activities of the brain. It also becomes mandatory to know that GABA receptors are the chemical messenger used by the nerve cells in order to easily communicate with each other. With a continuous demand as prescribed by the customers, the platform of UKSleepingPill has introduced Zopiclone amid the market abreast with its over-the-counter distribution. The website has introduced the drug keeping the consumer’s needs in mind. The launch of this drug is scientifically proven and tested aims in improving the body’s performance. If you are in a need of a treatment via which you may easily fall asleep then, Zopiclone is what the best doorway towards the same. Henceforth, with such availability of the drug at the UKSleepingPill’s platform, you can easily avail the same either online or over-the-counter at cost-effective prices while not depriving of the discounts offer. UKSleepingPill is the best-considered platform especially because of its service providers where each one of them is engaged in the distribution of the drug while catering to the consumer’s necessities and altering their doubt if any. The services of uksleepingpill are broadened in all over the United Kingdom via which consumers are catered with its easy online availability and distribution, globally. Additionally, their services are not restricted to Zopiclone instead, the platform is also engaged in the distribution of varied drugs such as Zolpidem , Xanax, Tramadol etc. All such drugs also get distributed with the great consideration of its consumption in specified time slots. About the company: UK Sleeping Pill is a one-stop platform for all forms of highly effective drugs especially when it comes to Zopiclone. The platform has established its benchmarks in a pharmaceutical domain. Since the day of its conceptualization, the platform has also achieved a huge clientele in the shortest duration. Owing to such of its facilitation, the company also boasts about its comprised personnel of the services providers where each one of them leverages on the broader experience and the knowledge of decades as well. (Added: Fri Mar 15 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Therapeutic Nuclear Medicines Maket to Significant Growth Foreseen by 2018- 2028 -

  

  Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendation owing to no proven significant adverse effects.

  In the backdrop of the growing criticality of a more reliable, safer, and lesser harmful line of treatment for cancers, therapeutic nuclear medicines are being increasingly perceived as the potential treatment for cancer patients. Moreover, consistently surging instances of bone metastases further supports adoption growth, in the therapeutic nuclear medicines market.

  Just-under 10% Annual Growth Projected for Radiopharmaceuticals Adoption

  A recent market research intelligence by Future Market Insights focuses on the deep-dive evaluation of global therapeutic nuclear medicines landscape, emphasizing the analysis of the most influential factors responsible for surging acceptance of radiopharmaceuticals in treating a range of cancers and a few other chronic conditions.

  The study projects robust progress for the global radiopharmaceuticals market in coming years, reportedly driven by remarkable adoption in the treatment of prostate cancer. In 2019, the global demand for therapeutic nuclear medicines is expected to grow at a 9.7% annual rate, and maximum adoption is estimated by cancer research institutes at a global level.

  • North America, jointly with Western Europe, represents more than 65% share of the total market value.

  • Outpacing developed regional markets, the radiopharmaceuticals market in China and emerging economies across Asia Pacific, Latin America, and Middle East & Africa are slated for higher year on year revenue growth of over 12% in 2019 and ahead.

  • China is reportedly the most lucrative market for penetration of therapeutic nuclear medicines, which is attributed to an expanding cancer patient pool in the country and a consistently surging rate of radiopharmaceuticals recommendation.

  Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2930

  Top Three Companies Account for More than 87% Market Value Share

  A highly consolidated marketplace, global therapeutic nuclear medicines landscape is dominated by Bayer AG that currently accounts for just-under 80% revenue share in market. The top three players include GE Healthcare and Novartis AG other than Bayer, which collectively cover over 87% of the total valuation of radiopharmaceuticals market. While exceptional sales and success rate of Xofigo have been prominently retaining Bayer’s top position in the global market, strategic acquisitions are identified to be the key strategy behind Novartis’ success at a global level.

  Thorough assessment of the competitive landscape of global therapeutic medicines market reveals a few prominent developmental strategies adopted by a majority of key companies operating in radiopharmaceuticals landscape –

  • Investments in R&D of targeted cancer therapeutics

  • Stronger supply chain and more streamlined distribution network

  • Improved flagship product sales

  • Strategic collaborations with pharma/biopharmaceutical companies

  • Contractual relationships with domestic/regional stakeholders

  • Strategic deals with internationally recognized cancer research institutes

  Over 20% Growth Forecast for Erbium-169

  Radium-223 has been the highest recommended type of radionucleotide in radiopharmaceuticals market. While it currently accounts for a whopping 78% share in the global market revenue, it is more likely that Erbium-169 that has been witnessing higher traction in recent past would witness relatively higher revenue growth in coming years. The report forecasts over 20% year on year revenue growth for Erbium-169 in 2019.

  Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-2930

  Exceptional Growth Projections for Thyroid & Brain Cancer

  While over half the global market value is accounted by the adoption of therapeutic nuclear medicines for treatment of prostate cancer, bone metastases also accounts for sizable revenue generation in the market. Brain tumor and thyroid cancer are likely to emerge highly lucrative targets for manufacturers of therapeutic nuclear medicines, according to the report.

  (Added: Thu Mar 14 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• Global Glycated Haemoglobin Testing Market to Witness Rapid Development During the Period 2020 - Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to determine the how well the level of glucose is controlled over time. North America dominates the global market for glycated haemoglobin testing due high diabetic prevalence and easily accessible modern healthcare facilities. Asia Pacific followed by the Europe is expected to show high growth rates in the next five years in global glycated haemoglobin testing market. Some of the key driving forces for glycated haemoglobin testing market in emerging countries are increasing prevalence of diabetics and increasing awareness about diabetics. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/3219 In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market. In addition, increasing healthcare awareness is also fuelling the growth of global glycated haemoglobin testing market. However, presences of substitutes such as test strips, glucose meters, lancets and continuous blood glucose meter for monitoring diabetes and high test cost are some of the major factors restraining the growth for global glycated haemoglobin testing market. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/3219 Increasing healthcare facilities would lead to growth in glycated haemoglobin testing market in Asia. In addition, rapid commercialization of devices for diabetes testing would develop opportunity for global glycated haemoglobin testing market. However, presence of limited approval for assay of glycated haemoglobin testing could lead a challenge for global glycated haemoglobin testing market. Some of the trends for global glycated haemoglobin testing market are increasing mergers and acquisitions, which would help in improving measurement of glycated haemoglobin and point of care haemoglobin A1c testing. Some of the major companies operating in the global glycated haemoglobin testing market are Abbott Laboratories, Roche Holdings AG, Alere Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bayer AG, ARKRAY Inc., Randox Laboratories Ltd., Tosoh Corp. and A. Menarini Diagnostics Ltd. (Added: Thu Mar 14 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• After 8.5 years of striving the results are positive and worth it. - After 8 years of RnD Herbsmedicure came up with the sugar free, 101 Ayurvedic and 140% Vegetarian medicine which helps male to regain their lost strength and stamina. Due to which many families and relationship were destroyed. Herbsmedicure launched the ayurvedic kit which consists of singh shakti oil , powder and capsules which improves the testosterone levels, increase stamina and better sperm quality. Herbs which are majorly found in Africa and eastern asia are main components of Singh Shakti Kit. And few herbs like ashwagandha , shilajit, safed musli and the major ingredient swarn bhasm are of best quality which are responsible for giving result from 1 day use. Maximum intimacy problems can be sought through this ayurvedic kit which is available online and offline for customer convenience. (Added: Thu Mar 14 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Revealing the Emergency Relocation Facility by Vedanta Air Ambulance Services - Thursday, March 14, 2019:- As the requirement of the Emergency Air Ambulance Service is very necessary in the field of shifting the patient which consists of the emergency medical evacuation/transportation Life-Support Equipment of the BLS (Basic Life Support) ambulance service which provides non-ambulatory and bed-ridden persons a means of transport to and from place A to B which shall be accompanied by a well-Aired nurse/paramedic staff to support the best experience of the medical tourism. Some of the equipment which normally used in BLS Air ambulance is: - Cardiac monitor, pulse oximeter, oxygen, scoop, spine board, medicine box, stair chair and many more which are required to facilitate the shifting facility. Now the Advance Cardiac Life-Support Air Ambulance Consists of the following faculty and the facility… ACLS Air Ambulance are well-equipped Setup and staffed by the highly Aired nurse or paramedics with doctor ready to observe the patient situation in the emergency situations where patients require a higher level of care than regular support which is available in (BLS) Air Ambulance can provide. Now Vedanta Air Ambulance Service in Darbhanga is also available to serve the needed one with the fascinating services. Standard equipment which is used inside the ACLS Air Ambulance Setup is: - Defibrillator, Cardiac Monitor, Ventilator, B.P Apparatus, Oxygen Therapy - Re-breathing circuit, Suction kit, Collapsible wheelchair, Mechanical Ventilation Support, Medical kits, Medical Drugs, Blood pressure cuff (Sphygmometer), Pulse ox-meter, Syringe pump, Scoop stretcher, Cardiac Support, and many more. With all the Magnificent and Advance facility Vedanta Air Ambulance Service in Dibrugarh is ready to serve you for all the medical evacuation support with the Expertise team of MD Doctors and the EMT Specialist Support.  Web @ https://www.vedantaairambulance.com/air-ambulance-in-dibrugarh/ (Added: Thu Mar 14 2019 Hits: 47 Rating: 0.00 Votes: 0) Rate It

• Veterinary Services Global Market Report To 2022 - Veterinary services provide healthcare for animals - especially pets, farm animals, and animals kept in zoos and wildlife parks. Healthcare is required in cases of disease or injury and for health maintenance and management. This industry comprises licensed veterinary practitioners who practice veterinary medicine, dentistry or surgery for animals. Veterinary Services Global Market Report 2019 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global Veterinary Services industry. Order the report at: https://www.thebusinessresearchcompany.com/report/veterinary-services-global-market-opportunities-and-strategies-to-2021 • The Veterinary Services market size characteristics section of the report defines and explains the market. • The Veterinary Services market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market. • Veterinary Services Industry segmentations break down the market into sub markets. • The regional and country breakdowns section gives an analysis of the Veterinary Services market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. • Competitive landscape gives a description of the competitive nature of the Animal Hospitals market , market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. • The Veterinary Services trends and strategies section highlights likely future developments in the market and suggests approaches companies can take to exploit this. • The Animal Hospitals market section of the report gives context. It compares the Veterinary Services market with other segments of the Global veterinary healthcare market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, Veterinary Services indicators comparison. Scope Markets covered: Animal hospitals and veterinary clinics and veterinary laboratory testing services Companies mentioned: VCA, Banfield Pet Hospital, Greencross Limited, CVS Group Countries: USA, UK, Germany, France, Italy, Spain, Russia, Brazil, Australia, China, India, Japan Regions: Asia-Pacific, North America, South America, Western Europe, Eastern Europe, Middle East, Africa. Time series: Five years historic and forecast. Data segmentations: country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes. Download a sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=799&type=smp About The Business Research Company: The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally. Contact Information The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company (Added: Thu Mar 14 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• Contract Research Organizations Global Market Report To 2021 - A Contract Research Organization (CRO) is a service provider, which offers end-to-end solutions in conducting clinical trials for biopharmaceutical and medical device companies. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. Contract Research Organizations Global Market Report 2019 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global Contract Research Organizations industry. Order the report at: https://www.thebusinessresearchcompany.com/report/contract-research-organizations-global-market-opportunities-and-strategies-to-2021 • The Contract Research Organizations market characteristics section of the report defines and explains the market. • The CRO Drug Discovery market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market. • Contract Research Organizations market segmentations break down the market into sub markets. • The regional and country breakdowns section gives an analysis of the Contract Research market size in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. • Competitive landscape gives a description of the competitive nature of the Contract Research Organizations market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. • The CRO Industry trends and strategies section highlights likely future developments in the market and suggests approaches companies can take to exploit this. • The CRO Drug Discovery Market section of the report gives context. It compares the Contract Research Organizations market with other segments of the Global Healthcare market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, Contract Research Organizations indicators comparison. Markets covered: 1) By Type of Services - drug discovery, preclinical studies, phase 1, phase 2, phase 3 ,phase 4 and others 2) By Therapeutic Area - oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and others Companies mentioned: IQVIA, Laboratory Corporation of America Holdings, ICON Plc , PAREXEL and PPD.  Countries: USA, UK, Germany, France, Italy, Spain, Russia, Brazil, Australia, China, India, Japan Regions: Asia-Pacific, North America, South America, Western Europe, Eastern Europe, Middle East, Africa. Time series: Five years historic and forecast. Data segmentations: country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes. Download a sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=791&type=smp About The Business Research Company: The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally. Contact Information The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company (Added: Thu Mar 14 2019 Hits: 26 Rating: 0.00 Votes: 0) Rate It

• Demand for Cell Based Assays to Witness Rapid Surge During the Period 2020 - Cell based assay refer to a technique of analysis of living cell on the basis of different parameters. Cell based assays are used to measure virtually of cellular or biochemical functions. In cell based assays, functional cells are used as diagnostic tools in research for new drugs. Cell based assays are used by pharmaceutical companies, academic research institutes, biotechnology companies, government institutions, contract research organizations and others. Cell based assays help to measure cell proliferations, motility, toxicity, production of a measurable product and morphology in diagnostics and drug discovery. Cell based assays facilitate research in the area of stem cells, cancer, immunology and others. On the basis of application, cell based assay market can be classified into drug discovery, predictive toxicology, basic research, ADME studies and others. North America, followed by Europe, has the largest market for cell based assays due to increasing drug related research, development activities, rise in adoption of cell based assay platforms and large number of pharmaceutical and biotechnology companies in this region. Asia is expected to show high growth rate in the cell based assays market in next few years due to technological advancement, rise in investments in R&D includes life science research and drug discover outsourcing in the region. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/3204 Increasing research activities in druga discovery, technological advancement, rise in demand for biological drugs, government expenditure, rising need for toxicity screening in drugs are expected to drive the market for cell based assays. In addition, significant advantages of cell based assay, innovations in technological advanced products and need to reduce costs associated with drug discovery are expected to drive the market for cell based assays. However, lack of skilled professionals, stringent intellectual property rights and high cost of instruments are some of the factors restraining the growth for global cell based assays market. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/3204 Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in cell based assays market. In addition, emergence of new technologies such as 3D cell based assays, advanced detection technologies, increasing requirement for toxicity screening and broadened applications of cell based assays are expected to offer new opportunities for global cell based assays market. However, complexity of high throughput screening (HTS) assay, assay optimization and standardization are some of the challenges for the global cell based assays market. Some of the major companies operating in the global cell based assays market are Becton, Dickinson and Company, GE Healthcare, Discoverx, Promega Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Perkinelmer, Inc. and Merck KGaA. (Added: Thu Mar 14 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Global 3D Cell Culture Market is Expected to Account for US$ 2,717.6 Mn by 2020 - According to a new market report titled “Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020”, published by Persistence Market Research, the global 3D cell culture market was valued at US$ 586.1 Mn in 2014 and is expected to expand at a CAGR of 29.1% to account for US$ 2,717.6 Mn by 2020. 3D cell culture refers to a process of growing cell culture in a 3D environment. It is an advanced cell culture technique that overcomes limitations of 2D cell culture in terms of cellular characteristics and behavior. Need for developing a cell culture method which can accurately stimulate normal cell morphology, proliferation, differentiation, and migrations led to the development of 3D cell culture techniques. Effect of drug doses can be studied more effectively in 3D cell culture as compared to conventional 2D cell culture, as cells grow more realistically in the former. Globally, the 3D cell culture market is witnessing significant growth due to the rising investment by major players in the market, increasing research related activities, and rising demand for organ transplantation. Moreover, 3D cell culture’s ability to replace the animal in research and pharmaceutical testing is also driving the growth of the market. However, budgetary constraints faced by small and medium-sized laboratories and lack of consistency in 3D cell culture products restrains the growth of the 3D cell culture market. The market was valued at US$ 586.1 Mn in 2014 and expected to account for US$ 2,717.6 Mn by 2020 at a CAGR of 29.1%. Request Sample Report@ https://www.persistencemarketresearch.com/samples/3329 Europe was the largest market for 3D cell culture in 2014. This is mainly due rising investments in 3D cell culture market and increasing research related activities. The Europe market for 3D cell culture was valued at US$ 234.4 Mn in 2014 and is expected to account for US$ 1,067.8 Mn by 2020 at a CAGR of 28.7%. On the basis of technology, microchips are the fastest growing segment. On the basis of application, drug discovery is the largest segment in the 3D cell culture market. Among end users, biotechnology and biopharmaceuticals industries segment is the fastest growing segment in the 3D cell culture market. Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Corning Incorporated, and Becton, Dickinson and Company are some of the leading players in the global market of 3D cell culture. Some of the other major players in 3D cell culture market are 3D Biotek LLC, Lonza Group, 3D Biomatrix, Inc., InSphero AG, Reinnervate Ltd, and Global Cell Solutions, Inc. The 3D cell culture market is segmented as follows: By Technology Extracellular Matrices or Scaffolds Bioreactors Gels Scaffold-free Platforms Microchips By Application Research Drug Discovery Tissue Engineering Clinical Applications Stem Cell Biology Request Report TOC@ https://www.persistencemarketresearch.com/methodology/3329 By End User Research Laboratories and Institutes Biotechnology and Biopharmaceutical Industries Hospitals and Diagnostics Centers (Added: Thu Mar 14 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Sales of Adhesion Barriers to Record Exponential Growth During 2018-2026 - Adhesion barriers or anti-adhesions are medical implants, used post-surgeries to reduce or prevent internal adhesion (scarring) by separating tissue and organs, resulting in faster recovery. Available in gel, film, and liquid formulations, the sterile, transparent and highly viscous gels and collagen and gelatin-laden film-based adhesion barriers are highly preferred in all forms of surgery. Growing number of patients opting for surgeries as a preferred treatment option (mostly used in cardiovascular surgeries), increasing geriatric population and corresponding health-related issues, and increasing awareness about severe post-surgery complications like adhesion formation, are some factors projected to drive the global adoption of adhesion barriers over the forecast period of 2018-2026. As per a recent market analysis by Persistence Market Research, the global adhesion barriers market is expected to expand at a robust 6.9% CAGR over the forecast period, with a market valuation of US$ 3,592.1 Mn by 2026. With clear market domination through 2017, North America adhesion barriers market is expected to represent highest incremental opportunity through 2026 too, attributable to product innovation and entry of new players. Moreover, increasing number of cardiovascular interventions, such as coronary revascularization and coronary artery bypass graft surgery (CABG), is expected to drive the global adhesion barriers market from 2018 to 2026. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/3202 Procedures including laparoscopy and laparotomy predominantly gives rise to internal scarring. Owing to advancements in medical procedures and significant investments in the healthcare industry coupled with increasing awareness among the patients, Asia-Pacific is likely to be a fast growing region for adhesion barriers. Considering growth prospects in emerging markets, companies like Sanofi, Anika Therapeutics, and Baxter are competing to capture the maximum share in these markets. Key players in the highly fragmented, oligopolistic global adhesion barriers market includes Baxter, Johnson & Johnson (Ethicon Inc.), Anika Therapeutics, Inc., Sanofi, FzioMed, Inc., Betatech Medical, Integra LifeSciences Corporation, Tissuemed Ltd., Hangzhou Singclean Medical Products Co., Ltd., and Symatese. Companies are foreseen to capitalize on the growth potentiality of adhesion barriers market by focusing on acquisitions and partnerships to expand business presence and distributor network coupled with product portfolio build-up. Manufacturers are also entering into direct supply agreements with hospitals to increase product penetration and sales. A large number of players in the global adhesion barriers market are also investing in R&D for more advanced and accurate product innovations to solve surgery-related issues and leverage untapped market. Adhesion barriers are likely to prove extremely advantageous in operating patients with patients with orthopedic, cardiovascular diseases, gynecological, and amputations owing to diabetes. Another innovation catching the attention of manufacturers includes second generation adhesion barriers, pegged to be more effective compared to the first generation adhesion barriers. The key players are also working on the cost structure model to reduce the overall cost of the adhesion barriers. Manufacturers are developing cost-effective adhesion barriers with lower pricing, to gain respective market shares and consumer base. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/methodology/3202 Despite rapid adoption of adhesion barriers, stringent federal approvals for new products could have an adverse effect on the global adhesion barriers market. (Added: Thu Mar 14 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Global Dental Implants Market Will reach $7,879.5 million in 2020 - According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants - Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020. Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020. Some of the major drivers which help in increasing demand for dental implants are rising aging population and growing concern for oral healthcare. Rising demand for cosmetic dentistry also supports the growth of dental implants market. High cost of dental implants surgery in countries such as the U.S. and the U.K. supports the growth of medical tourism in different part of the world including Malaysia, Hungary, Costa Rica, and India. However, limited reimbursements for dental implants surgery are restraining the growth of the dental implants market. Various technological advancements in dental implants such as Computer Aided Design (CAD), 3D imaging, mini dental implants, laser dentistry, sedation dentistry, and nanotechnology have improved dental surgical procedures. Request Sample Report@ https://www.persistencemarketresearch.com/samples/2821 Europe is the largest market for the global dental implants due to growing concern for oral hygiene, increasing clinical adoption of dental implants therapy and technological advancements. Some of the fastest growing markets for dental implants in Europe are the U.K., France and Germany. Titanium implants is the largest material based market and is expected to grow at a CAGR of about 9.8% from 2014 to 2020. The dental implants market in North America is expected to witness moderate growth attributed to aging population, rising awareness about oral health and technological advancement in dental implants surgery procedures. Adoption of advanced dentistry by North American people also plays important roles in driving the growth of the dental implants market. According to the American Dental Hygienists’ Association (ADHA), approximately 75% of American adults were suffering from various forms of gum diseases in 2008. However, Asia Pacific is the fastest growing dental implants market. Growing concern about oral health and medical tourism are some factors driving the growth of the dental implant in the Asia Pacific market. Institut Straumann AG is one of the leading players in the dental implants market. Other major players of dental implants market include Nobel Biocare, DENTSPLY International Inc. and Zimmer dental Inc., 3M Company and Neoss International. Request Report TOC@ https://www.persistencemarketresearch.com/methodology/2821 The dental implants market is segmented as follows: Dental implants market, by material Titanium Zirconium Dental implants market, by procedures Root-form implants Plate-form implants (Added: Thu Mar 14 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Alzheimers conference 2019 - The theme of the conference is “Unearthing the Advancements in Neurodegenerative Diseases”. Alzheimers 2019 Conference is on June 10-11, 2019 at Dublin, Ireland with theme “Unearthing the Advancements in Neurodegenerative Diseases”. (Added: Thu Mar 14 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Soft Tissue Repair Market - Soft tissue repair is a process of replacement of destroyed or injured tissue by healthy tissue. One of the key factors driving the market is the rise in a number of accidents and accidental injuries. This is leading to the soft tissue injuries in ligaments, muscle, and tendons. Soft tissue injuries are being treated with soft tissue fixation devices and scaffolds. Increasing number of sports injuries is also driving the demand for soft tissue repair. The most common and critical injury among sports people is Traumatic Brain Injury (TBI). In order to treat TBI, a majority of physicians use tissue scaffolds, this helps in protecting the injured area from a foreign body. The demand for soft tissue repair products is also increasing in the hospitals to deal with the injuries caused due to accidents. With the development of advanced devices, the demand for a minimally invasive procedure is also increasing. This is fueling the growth in the global soft tissue repair market. In recent years, the demand for stem cell and tissue engineered products for treating various diseases has also increased. Moreover, companies are investing in the advanced research and development of new soft tissue repair products. According to the report by Persistence Market Research (PMR), the global soft tissue repair market is expected to witness steady growth during the forecast period 2017-2024. The global market for soft tissue repair is also estimated to bring in more than US$ 7,000 Million revenue by the end of 2024. Request Sample Report@ https://www.persistencemarketresearch.com/samples/4448 Soft Tissue Repair to Witness Largest Application in Orthopedics in the Global Soft Tissue Repair Market Based on the product type, allograft is likely to witness the highest growth in the global market for soft tissue repair. By the end of the forecast period, allograft is projected to surpass US$ 3,000 Million revenue. On the basis of application, soft tissue repair is likely to find largest application in orthopedics throughout the forecast period 2017-2024. Orthopedics is estimated to surpass US$ 1,000 Million revenue towards the end of 2024. By the end user, hospitals are expected to see a significant growth in the global market for soft tissue repair. By 2024 end, hospitals are estimated to bring in more than US$ 4,000 Million revenue. North America to Lead the Global Soft Tissue Repair Market North America is expected to remain dominant in the global market for soft tissue repair in the global market for soft tissue repair. By 2024 end, North America is projected to exceed US$ 3,000 Million revenue. Presence of advanced healthcare infrastructure and increasing investment by the government in the development of healthcare facilities and advanced treatment methods are some of the factors driving the demand in the soft tissue repair market in the region. Major companies are also conducting research activities to develop devices and products that are technically advanced for soft tissue repair. Request Report TOC@ https://www.persistencemarketresearch.com/methodology/4448 Leading Players in the Global Soft Tissue Repair Market Baxter, B. Braun Melsungen AG, Johnson & Johnson Private Limited, Integra LifeSciences Corporation, C. R. Bard, Inc., Stryker, Anthrex, Inc., Acera Surgical, Inc., Acelity L.P. Inc., and Medtronic, are some of the key companies operating in the global market for soft tissue repair. (Added: Thu Mar 14 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Bioimpedance Devices Market -

  

  Multiple-Frequency Bioimpedance Devices to Witness Increasing Adoption Through 2028

  Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance devices market throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by gradual loss of kidney function over time. As per the National Kidney Foundation, Inc., 30 million American adults have Chronic Kidney Disease and millions of others are at high risk of developing CKD. The Glomerular filtration rate (GFR) is the best overall index for studying kidney function. Bioelectrical impedance or Bioimpedance is used for improved estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease and also to estimate muscle mass. Bioelectrical impedance analysis (BIA) can also be used to measure appendicular lean mass (ALM). The performance of these equations that include ALM BIA to estimate renal inulin clearance (GFR INU) can be compared with demographic variables and further used for modifications in diet for renal disease (MDRD) treatment.

  Widespread online marketing channels have tremendously increased the sale of portable as well as hand-held Bioimpedance devices in recent years. For Instance, a research study estimated that in 2015, approximately 70% of the population in the U.S. depended on online shopping portals for buying different items. Vendors operating in the Bioimpedance devices market are focusing on promotional strategies and online marketing to ensure better access to their devices and increase sales. Devices offered online also help vendors cut on operational and distribution costs. The online marketing channel also allows vendors to offer information about devices in their portfolio and gain access to both global and local markets. In addition, these online marketing websites provide a broad selection of high-quality Bioimpedance systems at more affordable costs.

  Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5563 

  Majority of the manufacturers in the Bioimpedance Devices makers are focusing on developing products that are portable and affordable. The popularity of portable Bioimpedance devices is increasing due to its various advantages. For instance, Bioimpedance Devices are noninvasive, reasonable, safe and easy to operate. These devices are light in weight and thus, are extensively used in home-based healthcare settings for monitoring health of the entire family. All these factors, cumulatively, are expected to drive the demand for portable Bioimpedance devices during the forecast period. Portable/ Hand-held Bioimpedance devices are also tremendously being opted by people for traveling purposes. For instance, the demand for ImpediMed SFB7, which is a hand-held Bioimpedance device, is increasing as this device is easy to carry. Technological advancements to enhance the quality of Bioimpedance devices and increase patient compliance are also projected to drive the growth of the market over the forecast period.

  Multiple-frequency Bioimpedance Devices are highly preferred because these devices can measure impedances in various frequencies. This provides a better and efficient estimation of fat free mass, total body water and intra and extra cellular water. Single frequency Bioimpedance devices can calculate fat free mass and total body water but these devices are not capable of estimating intra and extra cellular body water. Increasing popularity and growing awareness about multiple-frequency Bioimpedance devices is expected to boost market growth for Bioimpedance devices over the forecast period.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-5563

  FMI has segmented the global Bioimpedance Devices market by product type, modality and end user. The Bioimpedance Devices market, by product type, is segmented into Single-frequency Bioimpedance Devices and Multiple-frequency Bioimpedance Devices. By Modality, the Bioimpedance devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices. Bioimpedance Devices, by end users, are segmented into Hospitals, Specialty Clinics, Rehabilitation Centers and Others. Region-wise segmentation includes North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. The wired Bioimpedance devices segment in the Bioimpedance Devices market is expected to witness a significant growth during the forecast period.

  The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.

  (Added: Thu Mar 14 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Avail on-call Assistance to Hire Least-cost Vedanta Air Ambulance Service in Bokaro - March 14, 2019- Do you want to shift your loved ones in best and advanced Air Ambulance Service provider so, Vedanta Air Ambulance Service now in Bhopal with the best medical facility. This Air Ambulance is one of the best and emerging Air Ambulance Service provider all over in India which has both Medical Charted Aircraft and Commercial Airline are available for patients to care so, what are you waiting for visiting our company and save your loved one's life. Air Ambulance from Bhopal fulfills all the essential supplies not only to the patients but also the guests, it is because of It does charge the most inexpensive price, affordable cost and least range booking series by which the people can turn their intentions to book their air ambulance services calls. This is only one service provider which has 24 hours service obtainable anytime and somewhere round the clock. We prefer call booking amenities through online and offline. Reliable and Secure Service with Medical Team: Vedanta Air Ambulance from Bokaro provides all the emergency equipment’s and fittings hi-tech, authorized and contemporary founded by which the serious patients do not get any problems during their medical transposition from one city to another city under their review. Our Company Prefers These Advanced Facilities: They get effortlessly both Air Ambulance like Private and Commercial We provide complete quality bearing the best service organization transferring to the needy in Air Ambulance Service We give the lower and lighter burden concerning Air Ambulance Service We provide the maximum time knowledgeable and skilled medical team through Air Ambulance We always prefer low-cost and reasonable fare to the guest and bed to bed transfer service from one city to another city and anywhere in India at a short time duration. We preset 24/7 hours and 365 days for patients care and there is no extra cost or hidden price are available. Web@ https://www.vedantaairambulance.com/air-ambulance-in-bhopal/ More@ https://www.vedantaairambulance.com/air-ambulance-in-bokaro/ (Added: Thu Mar 14 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Your Search for Online Fitness and Nutrition Coaching is Over - Virtuosity Fitness offers a comprehensive fitness and nutrition program for clients to receive a customized program at a fraction of the cost that a personal trainer costs. Atlanta, GA, March 14, 2019 -- Virtuosity Fitness has just launched their online fitness coaching platform for clients anywhere to sign up. Fitness programs are customized to their clients' goals and current abilities. These programs are delivered through a mobile application with full descriptions and pictures and videos of all exercises for the client to understand how to execute the workout. Virtuosity Fitness coaches clients in CrossFit, Olympic Weightlifting, and general fitness. Reach your coach at don@virtuosityfit.com to learn more. In addition to fitness and strength and conditioning programs, Virtuosity Fitness offers nutrition coaching that is simple to understand and easy to sustain over the long term. No crazy diets used and no restrictions that leave you craving foods you "aren't allowed" to eat on other diets. If you're looking to lose weight, pack on muscle mass, or improve your performance in a sport, reach out to don@virtuosityfit.com to learn more. www.virtuosityfit.com has a full description of the programs offered. Contact: Don Waldera Virtuosity Fitness Atlanta, Georgia don@virtuosityfit.com https://www.virtuosityfit.com/ (Added: Thu Mar 14 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Pernicious Anemia Treatment Market to Witness Huge Growth in 2025 - Anemia is a condition where blood is deficient in red blood cells (RBCs). Pernicious anemia occurs when the body’s capacity to absorb vitamin B12, which is required to make healthy red blood cells, is reduced. It is a rare condition. As per the Journal of Blood Medicine, the prevalence of pernicious anemia is about 0.1% in the normal population, while in aged people (people over 60 years) the prevalence is about 1.9%. Previously, the disease was incurable due to lack of available treatment options. However, it is now easily treatable due to availability of medicines. The symptoms of pernicious anemia are not severe initially, and therefore it is difficult to diagnose. Commonly occurring symptoms include weakness, headaches, weight loss, and in rare cases some neurological problems. The most important sources of vitamin B12 include meat, eggs, poultry, dairy products, and nutritional supplements. In moderate to severe cases, vitamin B12 injections are provided to the patient to counteract deficiency symptoms. Vitamin B12 is available in the form of cyanocobalamin or hydroxocobalamin injections. When vitamin B12 levels are close to normal after treatment with injections, oral doses in the form of pills, sprays, and gels can be provided. Report Overview: https://www.transparencymarketresearch.com/pernicious-anemia-treatment-market.html High prevalence of the condition is a major factor likely to drive the global pernicious anemia treatment market during the forecast period. Development of pipeline products, high number of women of reproductive age, unhealthy lifestyle, and complications during pregnancy primarily in developing countries are some of the factors expected to propel the global pernicious anemia treatment market during the forecast period. Furthermore, increase in geriatric population, robust R&D, and improving health care infrastructure are projected to boost the global pernicious anemia treatment market. However, factors such as lack of awareness about health in several developing countries and high cost of drugs are anticipated to restrain the global pernicious anemia treatment market during the forecast period. The global pernicious anemia treatment market can be segmented based on the route of administration of drug, region, and distribution channel. Based on the route of administration, the pernicious anemia treatment market can be classified into parenteral, oral, nasal, and topical. The parenteral route segment accounts for a dominant share of the market due to higher availability and stability of drugs in the injectable form and major requirement of drugs in the injectable form during urgencies .In terms of distribution channel, the global pernicious anemia treatment market can be categorized into retail store, pharmacy, and e-commerce. The e-commerce segment is expected to account for a prominent market share in 2025 as shopping online offers convenience to consumers. Request for the Report PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40967 Based on region, the global pernicious anemia treatment market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to account for a significant share of the global pernicious anemia treatment market during the forecast period. Rise in incidence of the condition and unhealthy lifestyle are projected to drive the pernicious anemia treatment market in this region. Furthermore, increase in health care expenditure, advanced technology, increase in research activities, and rise in awareness about pernicious anemia are expected to augment the pernicious anemia treatment market in North America. Europe is also anticipated to hold a prominent share of the global pernicious anemia treatment market. The pernicious anemia treatment market in Asia Pacific is expected to expand at a rapid pace during the forecast period due to increase in health care expenditure, rise in geriatric population, surge in disposable income, high prevalence of chronic diseases, increase in awareness, and complications during pregnancy in many rural areas. Key players operating in the global anemia drugs market are AMAG Pharmaceuticals GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Sanofi, Galenica, Daiichi Sankyo, and Pharmacosmos. Request for the Discount on Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40967 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Mar 14 2019 Hits: 24 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... [>>]